Expertise in
1
conditions

Frederic R. Lucht

Saint-etienne-de-valoux, FR 
Expertise in
1
conditions
Saint-etienne-de-valoux, FR 

Overview

Frederic Lucht practices practicing medicine in Saint-etienne-de-valoux, France.

Mr. Lucht is highly rated in 1 condition, according to our data. His clinical expertise encompasses HIV/AIDS, Infective Endocarditis, Endocarditis, and Flu.

He is actively involved in clinical research, co-authoring 76 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Saint-etienne-de-valoux, France
Other Locations
Lyon, France
42055, France
Paris, France
Avenue Albert Raimond, 42055 Saint Étienne Cedex 02, Albert, 42055, France
Saint-priest-la-vetre, 42277, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers on the Occurrence of S. Aureus Infections in Hemodialysis Patients
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers on the Occurrence of S. Aureus Infections in Hemodialysis Patients
Enrollment Status: Terminated
Publish Date: December 18, 2024
Intervention Type: Other, Drug
Study Phase: Phase 4
Phase IIb Multicenter Randomized Comparative Study of Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for Chronic Inflammatory Bowel Disease
Phase IIb Multicenter Randomized Comparative Study of Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for Chronic Inflammatory Bowel Disease
Enrollment Status: Terminated
Publish Date: June 15, 2023
Intervention Type: Biological
Study Drugs: Prevenar 13, Pneumo 23
Study Phase: Phase 2
Decolonization of Patients Carrying S. Aureus Before Cardiac Surgery: Study of the Risk Factors Associated With Failure
Decolonization of Patients Carrying S. Aureus Before Cardiac Surgery: Study of the Risk Factors Associated With Failure
Enrollment Status: Completed
Publish Date: January 11, 2022
Intervention Type: Other, Procedure
Ex Vivo Evaluation of Immunity Activation Face to Staphylococcus Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients
Ex Vivo Evaluation of Immunity Activation Face to Staphylococcus Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients
Enrollment Status: Completed
Publish Date: December 17, 2020
Intervention Type: Biological
Study Phase: Not Applicable
Platelet-associated Inflammation in Severe Sepsis
Platelet-associated Inflammation in Severe Sepsis
Enrollment Status: Completed
Publish Date: July 10, 2020
Intervention Type: Other
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Enrollment Status: Completed
Publish Date: May 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae
Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae
Enrollment Status: Unknown
Publish Date: June 06, 2018
Intervention Type: Drug
Study Drug: Temocillin
Study Phase: Phase 4
View 6 Less Clinical Trials

76 Total Publications

T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 17, 2021

Frequently Asked Questions about Frederic R. Lucht

Is Frederic R. Lucht a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Frederic R. Lucht is classified as an Advanced expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Frederic R. Lucht participate in research or clinical trials?

Yes. Frederic R. Lucht has published 76 articles and abstracts on conditions like HIV/AIDS. You can view a list of Frederic R. Lucht's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lucht's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile